ArticleFrontiers in medicine2025
Neurofibromatosis type 2 misdiagnosed as amblyopia-a case report and literature review.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurofibromatosis type 2 (NF2) is characterized by bilateral vestibular schwannomas, and approximately 40-70% of affected children show ophthalmological involvement. Ophthalmological features may be the first sign of NF2; however, the symptoms associated with ocular lesions are diverse. The onset of NF2 is often obscure, resulting in missed or misdiagnosed cases. Herein, we report a case of NF2 in a child who initially presented with poor eyesight. The child had been treated for amblyopia for 7 years and was referred to the eye oncology department due to a lack of improvement in vision. At birth, a soft mass was noted scattered across the abdominal skin and scalp, which gradually increased in size over time. Ophthalmological examination revealed posterior subcapsular opacity in the right eye and an anterior retinal hamartoma in the left eye. Orbital and cranial magnetic resonance imaging (MRI) indicated that the T1 and T2 signals of multiple structures, including the cone, auditory nerve, trigeminal nerve, left oculomotor nerve, paravertebral, and sublingual region, were more uniform after enhancement. A genetic heterozygous mutation was detected, with no family history of the condition. In addition to this case, we collected and summarized 158 publicly reported cases of NF2 with ophthalmological characteristics. Among these cases, the incidence of visual impairment, strabismus, cataract, retinal anomaly, and retinal hamartoma was high, reaching 64, 38, 25, 23, and 16%, respectively. Through analysis and discussion of the clinical and imaging characteristics of NF2 ocular lesions, we aim to improve ophthalmologists' understanding of this disease, thereby reducing the rate of missed diagnoses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.